PFS Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$7.53M Buy
16,049
+13,023
+430% +$5.46M 0.12% 165
2023
Q1
$1.11M Buy
3,026
+554
+22% +$187K 0.02% 360
2022
Q4
$904K Sell
2,472
-274
-10% -$97.1K 0.02% 344
2022
Q3
$888K Buy
2,746
+901
+49% +$285K 16.13% 1
2022
Q2
$598K Buy
1,845
+280
+18% +$84K 0.01% 355
2022
Q1
$448K Buy
+1,565
New +$403K 0.01% 370
2020
Q2
Sell
-25,436
Closed -$3.53M 276
2020
Q1
$3.53M Buy
25,436
+5,125
+25% +$704K 0.15% 104
2019
Q4
$2.67M Buy
20,311
+4,682
+30% +$543K 0.1% 126
2019
Q3
$1.75M Buy
15,629
+4,705
+43% +$524K 0.08% 125
2019
Q2
$1.23M Buy
10,924
+6,030
+123% +$710K 0.06% 123
2019
Q1
$635K Buy
+4,894
New +$595K 0.03% 117

Other funds holding LLY

PFS Investments's LLY Position: Q2 2023 in Review

PFS Investments increased its Eli Lilly (LLY) stake by 430% in Q2 2023, buying an estimated $5.46M and bringing the position to 16,049 shares worth $7.53M. The position accounts for 0.12% of the portfolio, ranked #165.

PFS Investments first reported a position in LLY in Q1 2019 and has held it in 11 quarters since. 2,814 funds tracked by Wall St. Rank hold LLY as of Q2 2023.

  • PFS Investments held 16,049 shares of Eli Lilly worth $7.53M as of Q2 2023.
  • PFS Investments bought 13,023 Eli Lilly shares in Q2 2023, an estimated $5.46M.
  • Eli Lilly made up 0.12% of PFS Investments's portfolio in Q2 2023, its #165 holding.
  • PFS Investments first reported a position in Eli Lilly in Q1 2019 and has held it in 11 quarters since.
  • 2,814 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2023.

Based on PFS Investments's 13F filing for Q2 2023, filed 14 Aug 2023.